NCT06747611View on ClinicalTrials.gov

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 21, 2025

Primary Completion Date

March 15, 2028

Study Completion Date

March 15, 2028

Conditions
Alopecia AreataAlopecia TotalisAlopecia Universalis
Interventions
DRUG

Vancomycin, Neomycin and MTT capsules

patients will take 2 capsules per day for 14 days. These patients will then be clinically followed for a period of 24 weeks.

DRUG

Placebo capsules

patients will take 2 capsules per day for 14 days. These patients will then be clinically followed for a period of 24 weeks.

Trial Locations (1)

55455

RECRUITING

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

Columbia University

OTHER

lead

University of Minnesota

OTHER

NCT06747611 - Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata | Biotech Hunter | Biotech Hunter